Introduction {#S1}
============

A new histological classification of neuroendocrine tumors (NETs) was determined in the WHO 2010 classification, and the UICC TNM classification seventh edition or ENET classification proposed the staging of gastrointestinal NET ([@B1]--[@B3]). NETs arise from the whole organ, and gastrointestinal NET was traditionally divided by the embryological origin of the foregut, midgut, and hindgut. Midgut and hindgut NET arise in the large intestine and the variable histologic features of NET in this organ could complicate identification even when using identical WHO 2010 classifications. Furthermore, large clinicopathological data sets of NET based on the WHO 2010 classification are not available, and the utility of the WHO 2010 classification as a prognostic factor is not well established in NET of the large intestine. Recently, clinical guidelines for gastrointestinal NET were also proposed by NCCN and ENET ([@B4], [@B5]). However, the indication for local excision or endoscopic resection in small lesions is not fully determined ([@B6]). Similar to early colorectal adenocarcinoma, the clinicopathological association between colorectal NET and lymph node status in surgically resected cases has been studied to predict lymph node metastasis ([@B7], [@B8]). In this study, retrospective assessment of NET of the large intestine (colorectal and appendiceal NET) was performed among the 68 Japanese institutions allied with the Japanese Society for Cancer of the Colon and Rectum (JSCCR) to clarify the clinicopathological features of NET in the large intestine using WHO 2010 criteria. Next, using surgically resected rectal NET G1 and G2, the clinicopathological relationship with lymph node metastasis was analyzed to assess the current therapeutic algorithm.

Materials and Methods {#S2}
=====================

Pathological re-evaluations of NET according to the WHO 2010 criteria were performed in cases with NET of the large intestine removed from 2001 to 2011 in the 68 institutions of the JSCCR. The collected clinicopathological information was patient age, sex, tumor size, tumor location, pathological diagnosis based on WHO 2010 criteria, depth of tumor invasion, mitotic index \[\<2/10 high power fields (HPF), 2--20/10 HPF, or \>20/10 HPF\], Ki-67 labeling index (≤2, 3--20, or \>20%), and resection method (surgical, endoscopic, or other). Information of lymph node metastasis (present or absent) was collected in all surgically resected cases, and cases underwent radical surgery after the local resection were included in resected cases. These data were registered into a Web system developed by the JSCCR. Clinical outcome or prognosis was not investigated in this study. Clinicopathological features of NET in the large intestine were evaluated, and compared among rectal, colonic, and appendiceal NET, and the association between clinicopathological features and lymph node metastasis was assessed using surgically resected rectal NET G1 and G2 to estimate risk factors of lymph node metastasis in locally resected tumors. This study was approved by the review board in the JSCCR and National Cancer Center (2014-332).

Statistical Analysis {#S2-1}
--------------------

All continuous data were described as mean and SD in this study. As therapeutic strategy of NET in large intestine is divided by tumor size of 10 and 20 mm, case number and frequency of the tumors \<10, ≥10 and \<20, and ≥20 mm were calculated. Comparison of clinicopathological features among rectal, colonic, and appendiceal NET was performed using the χ^2^-test and Student's *t*-test.

Clinicopathological factors associated with lymph node metastasis in rectal NET G1 and G2 were assessed using χ^2^-test and Student's *t*-test, and multiple logistic regression analyses were performed to identify independent predictive factors of synchronous lymph node metastasis. A probability value of \<0.01 was regarded as statistically significant in this study.

Results {#S3}
=======

In this study, 760 cases from 68 institutions were entered and clinicopathological features were evaluated (Table [1](#T1){ref-type="table"}). Of the 760 tumors, 718 (94.5%) were located in the rectum, 30 (3.9%) were in the colon, and 12 (1.6%) were in the appendix. In total, 461 (60.7%) patients were men and 299 (39.3%) were women, with a mean age of 58.7 years. The frequencies of NET G1, G2, NEC (G3), and mixed adeno-neuroendocrine carcinoma (MANEC) were 672 (88.4%), 48 (6.3%), 30 (3.9%), and 10 (1.3%), respectively. Of the 760 NET, 468 were locally resected, and 292 were surgically resected with lymph node dissection, which included cases who underwent radial surgery after the local resection. As for tumor size, the mean size was 11.7 mm, and 497 tumors (65.4%) were smaller than 10 mm. Most tumors were limited to the mucosa or submucosa (657 cases, 86.4%), showed mitosis in \<2/10 HPF (694 cases, 91.3%), and had a Ki-67 index of ≤2% (675 cases, 88.8%). Lymphatic vessel invasion and blood vessel invasion were found in 136 (17.9%) and 173 (22.8%) cases, respectively. Lymph node metastasis was found in 108 cases of 292 surgically resected cases (37.0%). As for clinicopathologic differences among colonic, rectal, and appendiceal NETs, patient ages were different among them, significantly (*P* \< 0.01), and were in the order of colonic (68.6 ± 11.9 years), rectal (58.6 ± 12.4 years), and appendiceal NET (44.7 ± 22.6 years). Distribution of histological grade was also different between rectal NET and others. Compared with colonic and appendiceal NET, rectal NET was predominantly NET G1 (656 cases, 91.4%). However, colonic NET included more NET G3/NEC (14 cases, 46.7%) and MANEC (6 cases, 20.0%), and appendiceal NET included more NET G3/NEC (7 cases, 58.3%). Most of the local resections were performed in rectal NET (467/468 cases, 99.8%). Tumor sizes were 9.7 ± 12.3 mm for rectal NET, 51.3 ± 37.8 mm for colonic NET, and 28.8 ± 36.2 mm for appendiceal NET; rectal NETs were significantly smaller than colonic and appendiceal NET (*P* \< 0.01). The distribution of tumor depth is also different between rectal NET and others, and tumor depth in rectal NET was limited to the mucosa or submucosa in 684 cases (95.3%), while over half of colonic and appendiceal NET invaded the muscular layer or deeper (*P* \< 0.01). Concordant with WHO 2010 criteria, cases with low mitotic and Ki-67 indices were seen more often in rectal NET than in others. Lymphatic vessel and blood vessel invasions were more frequently seen in colonic NET than in rectal NET. Also, lymph node metastasis in surgically resected cases was seen more frequently in colonic NET than in others, significantly (*P* \< 0.01).

###### 

**Clinicopathological features of colorectal neuroendocrine tumor based on WHO 2010 criteria**.

                                                                                                                      Total cases   Rectal NET    Colonic NET   Appendiceal NET   Rectal vs. colonic (*P* value)   Rectal vs. appendiceal (*P* value)   Colonic vs. appendiceal (*P* value)
  ------------------------------- ----------------------------------------------------------------------------------- ------------- ------------- ------------- ----------------- -------------------------------- ------------------------------------ -------------------------------------
  No. of cases                                                                                                        760           718 (94.5%)   30 (3.9%)     12 (1.6%)                                                                               
  Age (years)                     Mean ± SD                                                                           58.7 ± 12.8   58.6 ± 12.4   68.6 ± 11.7   44.7 ± 22.6       \>0.01                           \>0.01                               \>0.01
  Sex                             Men                                                                                 461 (60.7%)   435 (60.4%)   20 (66.6%)    6 (50.0%)         0.50                             0.46                                 0.31
                                  Women                                                                               299 (39.3%)   283 (39.4%)   10 (33.3%)    6 (50.0%)                                                                               
  WHO 2010 criteria               NET G1                                                                              672 (88.4%)   656 (91.4%)   9 (30.0%)     3 (25.0%)         \>0.01                           \>0.01                               0.18
                                  NET G2                                                                              48 (6.3%)     44 (6.1%)     1 (3.3%)      2 (16.7%)                                                                               
                                  NET G3/NEC                                                                          30 (3.9%)     14 (2.0%)     14 (46.7%)    7 (58.3%)                                                                               
                                  MANEC                                                                               10 (1.3%)     4 (0.6%)      6 (20.0%)     0 (0%)                                                                                  
  Resection                       Surgically                                                                          292 (38.4%)   251 (35.0%)   29 (96.7%)    12 (100%)         \>0.01                           \>0.01                               0.52
                                  Locally                                                                             468 (61.6%)   467 (65.0%)   1 (3.3%)      0 (0%)                                                                                  
  Tumor size                      Mean ± SD                                                                           11.7 ± 16.9   9.7 ± 12.3    51.3 ± 37.8   28.8 ± 36.2       \>0.01                           \>0.01                               0.09
                                  \<10 mm                                                                             497 (65.4%)   490 (68.2%)   4 (13.3%)     3 (25.0%)         \>0.01                           \>0.01                               0.66
                                  ≥10 mm, \<20 mm                                                                     180 (23.7%)   176 (24.5%)   3 (10.0%)     1 (8.3%)                                                                                
                                  ≥20 mm                                                                              83 (10.9%)    52 (7.2%)     23 (76.7%)    8 (66.7%)                                                                               
  Tumor depth                     Limited to mucosa (%)                                                               32 (4.2%)     32 (4.5%)     0 (0%)        0 (0%)            \>0.01                           \>0.01                               0.25
                                  Invades submucosa (%)                                                               625 (82.2%)   652 (90.8%)   4 (13.3%)     1 (8.3%)                                                                                
                                  Invades muscularis propria (%)                                                      42 (5.5%)     39 (5.4%)     2 (6.7%)      1 (8.3%)                                                                                
                                  Invades into subserosa or non-peritonealized pericolonic or perirectal tissue (%)   38 (5.0%)     21 (2.9%)     9 (30.0%)     8 (66.7%)                                                                               
                                  Invades peritoneum or other organs (%)                                              23 (3.0%)     6 (0.8%)      15 (50.0%)    2 (16.7%)                                                                               
  Mitotic index (/10HPF)          \<2 (%)                                                                             694 (91.3%)   676 (94.2%)   9 (30.0%)     9 (75.0%)         \>0.01                           0.02                                 0.012
  ≤2, ≤20 (%)                     31 (4.1%)                                                                           25 (3.5%)     4 (13.3%)     2 (16.7%)                                                                                             
  \>20 (%)                        35 (4.6%)                                                                           17 (2.4%)     17 (56.7%)    1 (8.3%)                                                                                              
  Ki-67 index (%)                 ≤2 (%)                                                                              675 (88.8%)   659 (91.8%)   9 (30.0%)     7 (58.3%)         \>0.01                           \>0.01                               0.03
                                  \<2, ≤20 (%)                                                                        48 (6.3%)     42 (5.8%)     3 (10.0%)     3 (25.0%)                                                                               
                                  \>20 (%)                                                                            37 (4.9%)     17 (2.4%)     18 (60.0%)    2 (16.7%)                                                                               
  Lymphatic vessel invasion       Absent (%)                                                                          624 (82.1%)   607 (84.5%)   9 (30.0%)     8 (66.7%)         \>0.01                           \>0.01                               0.18
  Present (%)                     136 (17.9%)                                                                         111 (15.5%)   21 (70.0%)    8 (66.7%)                                                                                             
  Blood vessel invasion           Absent (%)                                                                          587 (77.2%)   572 (79.7%)   7 (23.3%)     8 (66.7%)         \>0.01                           0.27                                 \>0.01
                                  Present (%)                                                                         173 (22.8%)   146 (20.3%)   23 (76.7%)    4 (33.3%)                                                                               
  Lymph node metastasis           Absent (% in surgical cases)                                                        184 (63.0%)   166 (66.1%)   8 (27.6%)     10 (83.3%)        \>0.01                           0.22                                 \>0.01
  Present (% in surgical cases)   108 (37.0%)                                                                         85 (33.9%)    21 (72.4%)    2 (16.7%)                                                                                             

*Clinicopathologic features of colorectal neuroendocrine tumors removed from a Japanese cohort from 2001 to 2011 and retrospectively classified using the WHO 2010 criteria*.

*NEC, neuroendocrine carcinoma; NETs, neuroendocrine tumors; MANEC, mixed adeno-neuroendocrine carcinoma*.

Next, we investigated the risk factor of synchronous lymph node metastasis, especially in small rectal NET G1 and G2. At first, we evaluated the association between clinicopathological features and lymph node metastasis using all 233 surgically resected rectal NET G1 and G2. Clinicopatholgoical features are shown in Table [2](#T2){ref-type="table"}, and lymph node metastasis was found in 70 cases (30.0%) in these cases. Table [3](#T3){ref-type="table"} shows the association between clinicopathological features and lymph node metastasis. NET G2, large tumor size, tumor invasion into the muscularis propria or deeper, high mitotic index, high Ki-67 index, lymphatic vessel invasion, and blood vessel invasion were associated with lymph node metastasis in univariate analysis. Furthermore, lymphatic and blood vessel invasion were independent predictors of lymph node metastasis in multivariate analysis. Although NET G2 cases showed more lymph node metastasis than that seen in NET G1 cases, that was not an independent predictor of lymph node metastasis in rectal NET. Table [4](#T4){ref-type="table"} (A) shows the association between clinicopathological features and lymph node metastasis in surgically resected rectal NET G1 and G2 \<20 mm. Tumor size, lymphatic invasion, and blood vessel invasion were independent predictors of lymph node metastasis. NET G2 cases tended to show more frequent lymph node metastasis, but this difference was not statistically significant. Of 489 rectal NET G1 and G2 \<10 mm, 98 were surgically resected, and 391 were locally resected. The differences between them are shown in Table [5](#T5){ref-type="table"}. Surgically resected cases were larger and showed more frequent lymphatic vessel and blood vessel invasion than that seen with locally resected cases, and lymph node metastasis was seen in 9 cases (9.2%) of 98 surgically resected cases. A clinicopathological comparison between cases with and without lymph node metastasis is shown in Table [4](#T4){ref-type="table"} (B). Of the clinicopathological features, although not an independent risk factor in multivariate analysis, blood vessel invasion was found more frequently in cases with lymph node metastasis in the univariate analysis. The clinicopathological features of nine cases with lymph node metastasis are shown in Table [6](#T6){ref-type="table"}. All nine cases were NET G1, and the tumor depth was limited to the mucosa or submucosa. Importantly, eight of the nine cases showed either lymphatic or blood vessel invasion.

###### 

**Clinicopathological features of surgically resected rectal NET G1 and G2 based on WHO 2010 criteria**.

  Total cases                                                                                                 233
  --------------------------- ------------------------------------------------------------------------------- -------------
  Age (years)                 Mean ± SD                                                                       57.7 ± 12.0
  Sex                         Men                                                                             133 (57.1%)
                              Women                                                                           100 (42.9%)
  WHO 2010 criteria           NET G1                                                                          201 (86.3%)
  NET G2                      32 (13.7%)                                                                      
  Tumor size (mm)             Mean ± SD                                                                       12.9 ± 12.6
  Location                    Upper rectum                                                                    37 (15.9%)
                              Lower rectum                                                                    196 (84.1%)
  Tumor depth                 Limited to mucosa                                                               6 (2.6%)
                              Invades submucosa                                                               183 (78.5%)
                              Invades muscularis propria                                                      34 (14.6%)
                              Invades into subserosa or non-peritonealized pericolonic or perirectal tissue   10 (4.3%)
                              Invades peritoneum or other organs                                              0 (0%)
  Mitotic index (/10HPF)      \<2                                                                             212 (91.0%)
  ≤2, ≤20                     21 (9.0%)                                                                       
  Ki-67 index (%)             ≤2                                                                              202 (86.7%)
                              \<2, ≤20                                                                        31 (13.3%)
  Lymphatic vessel invasion   Absent                                                                          165 (70.8%)
  Present                     68 (29.2%)                                                                      
  Blood vessel invasion       Absent                                                                          149 (63.9%)
  Present                     84 (36.1%)                                                                      
  Lymph node metastasis       Absent                                                                          163 (70.0%)
  Present                     70 (30.0%)                                                                      

*Study population described in Table [1](#T1){ref-type="table"}*.

*NETs, neuroendocrine tumors*.

###### 

**Association between clinicopathological features and lymph node metastasis in surgically resected rectal NET G1 and G2 Lymph node metastasis**.

                                                                     Positive (70 cases)   Negative (163 cases)   *P* value (univariate analysis)   *P* value (multivariate analysis)
  --------------------------- -------------------------------------- --------------------- ---------------------- --------------------------------- -----------------------------------
  Age (years)                 Range (mean ± SD)                      56.3 ± 11.3           58.3 ± 12.2            0.24                              
  Sex                         Men                                    39                    94                     0.78                              
                              Women                                  31                    69                                                       
  Location                    Upper rectum                           7                     30                     0.11                              
                              Lower rectum                           63                    133                                                      
  WHO 2010 criteria           NET G1                                 54                    147                    *P* \< 0.01                       0.89
                              NET G2                                 16                    16                                                       
  Tumor size (mm)             Range (mean ± SD)                      16.6 ± 9.9            11.3 ± 13.3            *P* \< 0.01                       0.08
  Tumor depth                 Limited to mucosa or submucosa         45                    144                    *P* \< 0.01                       0.05
                              Invades muscularis propria or deeper   25                    19                                                       
  Mitotic index (/10HPF)      \<2                                    58                    154                    *P* \< 0.01                       
                              ≤2, ≤20                                12                    9                                                        
  Ki-67 index (%)             ≤2                                     16                    15                     *P* \< 0.01                       
                              \<2, ≤20                               54                    148                                                      
  Lymphatic vessel invasion   Absent                                 32                    133                    *P* \< 0.01                       *P* \< 0.01
                              Present                                38                    30                                                       
  Blood vessel invasion       Absent                                 28                    121                    *P* \< 0.01                       *P* \< 0.01
                              Present                                42                    42                                                       

*Study population described in Table [1](#T1){ref-type="table"}*.

*NETs, neuroendocrine tumors*.

###### 

**Association between clinicopathological features and lymph node metastasis in surgically resected rectal NET G1 and G2 \<20 and \<10 mm**.

  \(A\) Association between clinicopathological features and lymph node metastasis in surgically resected rectal NET G1 and G2 \<20 mm   \(B\) Association between clinicopathological features and lymph node metastasis in surgically resected rectal NET G1 and G2 \<10 mm                                                                                                                        
  -------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------- ------------- ------------- ------------- -------------------------------------- ------------ ------------- -------- -------
  Age (years; mean ± SD)                                                                                                                 55.5 ± 11.6                                                                                                                            58.2 ± 12.3   N.S                         Age (years; mean ± SD)                 57.1 ± 8.8   57.7 ± 12.3   N.S      
  Sex                                                                                                                                                                                                                                                                                                                     Sex                                                                        
  Men                                                                                                                                    30                                                                                                                                     85            N.S                         Men                                    5            51            N.S      
  Women                                                                                                                                  23                                                                                                                                     62                                        Women                                  4            38                     
  Location                                                                                                                                                                                                                                                                                                                Location                                                                   
  Upper rectum                                                                                                                           7                                                                                                                                      27            N.S                         Upper rectum                           0            21            N.S      
  Lower rectum                                                                                                                           46                                                                                                                                     120                                       Lower rectum                           9            68                     
  WHO 2010 criteria                                                                                                                                                                                                                                                                                                       WHO 2010 criteria                                                          
  NET G1                                                                                                                                 43                                                                                                                                     133           0.07                        NET G1                                 9            85            N.S      
  NET G2                                                                                                                                 10                                                                                                                                     14                                        NET G2                                 0            4                      
  Tumor size (mm; mean ± SD)                                                                                                             12.5 ± 3.5                                                                                                                             8.5 ± 3.8     *P* \< 0.01   *P* \< 0.01   Tumor size (mm; mean ± SD)             7.2 ± 1.6    6.1 ± 2.0     N.S      
  Tumor depth                                                                                                                                                                                                                                                                                                             Tumor depth                                                       N.S      
  Limited to mucosa or submucosa                                                                                                         40                                                                                                                                     131           0.02                        Limited to mucosa or submucosa         9            86                     
  Invades muscularis propria or deeper                                                                                                   13                                                                                                                                     16                                        Invades muscularis propria or deeper   0            3                      
  Mitotic index (/10HPF)                                                                                                                                                                                                                                                                                                  Mitotic index (/10HPF)                                                     
  \<2                                                                                                                                    45                                                                                                                                     139           0.03                        \<2                                    9            86            N.S      
  ≤2, ≤20                                                                                                                                8                                                                                                                                      8                                         ≤2, ≤20                                0            3                      
  Ki-67 index (%)                                                                                                                                                                                                                                                                                                         Ki-67 index (%)                                                   N.S      
  ≤2                                                                                                                                     42                                                                                                                                     134           0.02                        ≤2                                     9            87                     
  \<2, ≤20                                                                                                                               11                                                                                                                                     13                                        \<2, ≤20                               0            2                      
  Lymphatic vessel invasion                                                                                                                                                                                                                                                                                               Lymphatic vessel invasion                                         0.02     
  Absent                                                                                                                                 26                                                                                                                                     121           *P* \< 0.01   *P* \< 0.01   Absent                                 5            76                     
  Present                                                                                                                                27                                                                                                                                     26                                        Present                                4            13                     
  Blood vessel invasion                                                                                                                                                                                                                                                                       *P* \< 0.01   *P* \< 0.01   Blood vessel invasion                                             \<0.01   =0.01
  Absent                                                                                                                                 22                                                                                                                                     109                                       Absent                                 3            68                     
  Present                                                                                                                                31                                                                                                                                     38                                        Present                                6            21                     

*Study population described in Table [1](#T1){ref-type="table"}*.

*NETs, neuroendocrine tumors*.

###### 

**Clinicopathological difference between locally resected and surgically resected rectal NET G1 and G2 \<10 mm**.

                                                                     Treatment                   
  --------------------------- -------------------------------------- ------------- ------------- -------------
                                                                     391           98            
  Age (years)                 Range (mean ± SD)                      58.3 ± 12.7   57.6 ± 12.0   0.62
  Sex                         Men                                    238           56            0.50
                              Women                                  153           42            
  Location                    Upper rectum                           73            21            0.54
                              Lower rectum                           318           77            
  WHO 2010 criteria           NET G1                                 382           94            0.07
                              NET G2                                 9             4             
  Tumor size (mm)             Range (mean ± SD)                      6.2 ± 2.0     5.2 ± 2.0     *P* \< 0.01
  Tumor depth                 Limited to mucosa or submucosa         368           95            0.03
                              Invades muscularis propria or deeper   2             3             
  Mitotic index (/10HPF)      \<2                                    388           96            0.26
                              ≤2, ≤20                                3             2             
  Ki-67 index (%)             ≤2                                     383           95            0.54
                              \<2, ≤20                               8             3             
  Lymphatic vessel invasion   Absent                                 372           81            *P* \< 0.01
                              Present                                19            17            
  Blood vessel invasion       Absent                                 357           71            *P* \< 0.01
                              Present                                34            27            

*Study population described in Table [1](#T1){ref-type="table"}*.

*NETs, neuroendocrine tumors*.

###### 

**Lymph node metastasis in NET G1and G2 \<10 mm**.

  No   Age (years)   Sex   Tumor size (mm)   Invasion   Lymphatic invasion   Blood vessel invasion   WHO 2010 classification
  ---- ------------- ----- ----------------- ---------- -------------------- ----------------------- -------------------------
  1    71            M     8                 SM         \+                   \+                      G1
  2    49            F     6                 SM         −                    \+                      G1
  3    50            M     6                 SM         −                    \+                      G1
  4    61            M     8                 SM         \+                   \+                      G1
  5    62            F     8                 SM         −                    \+                      G1
  6    42            F     8                 SM         \+                   --                      G1
  7    63            M     4                 SM         −                    \+                      G1
  8    60            M     8                 SM         −                    −                       G1
  9    56            F     9                 SM         \+                   −                       G1

*Study population described in Table [1](#T1){ref-type="table"}*.

*NETs, neuroendocrine tumors*.

Discussion {#S4}
==========

In this study, we examined the clinicopathological association with synchronous lymph node metastasis in surgically resected rectal NET G1 and G2. Gastrointestinal NET without lymph node metastasis can be cured by local resection. Although many primary NETs themselves can be removed endoscopically, lymph node metastases can remain. Therefore, prediction of lymph node metastasis using the primary tumor is important to determine a patient's need for surgical resection with lymph node dissection. Tumor size and tumor depth have been reported to be important for the prediction of lymph node metastasis in rectal NET ([@B9], [@B10]). T stage in current ENET TNM and AJCC/UICC TNM classification was determined by tumor size and depth. ENET and NCCN guidelines recommended local resection in tumors \<20 mm and without muscular invasion which corresponding to pT1a and 1b ([@B4], [@B5]). However, our results from surgical specimens of rectal NET G1 and G2 revealed that lymphatic vessel and blood vessel invasion was the independent risk factors of lymph node metastasis. Then, 26.5% of lymph node metastasis was found in tumors smaller than 20 mm. Furthermore, 9.2% of lymph node metastases were found in tumors smaller than 10 mm, and most of these cases were positive for vascular invasion. Similar results were reported previously by Konishi et al. ([@B11]). They reported a 7% rate of lymph node metastasis in tumors smaller than 10 mm, and all cases had lymphatic vessel invasion. The JSCCR and Japan Neuroendocrine Tumor Society recommend, based on this result, local resection only for tumors smaller than 10 mm, and without muscular invasion or vascular invasion ([@B12]). There were no distinct guidelines about the indication of local resection during this study period of 2001 and 2011. Despite this, many clinicians in local institutions recommended surgical resection in tumors near 10 mm in size or cases with vascular invasion. Such a decision by local clinicians is thought to be reflected in the difference between surgically resected and locally resected cases in rectal NET \<10 mm, where 9.2% of cases were positive for lymph node metastasis. Therefore, clinicians should remember that some cases \<20 mm or even \<10 mm in size may show lymph node metastasis in rectal NET. However, good clinical results after endoscopic resection of NET have also been reported ([@B13]). Therefore, further study with follow-up data is required to determine the optimal treatment algorithm in small rectal NET. All institutions in this study have also entered into a pathology survey, and their assessment statuses were investigated ([@B14]). In this survey, 88.6% of these institutions routinely performed immunohistochemical and histochemical staining in the diagnosis of NET, and 90.3% of these institutions routinely performed immunohistochemical and histochemical staining to assess vascular invasion. Detailed pathology evaluations were also performed by institutions entered in this study. Inter-observer differences in the assessment of vascular invasion have been reported. However, this difference seemed to be affected by the tumor size. Many NETs were found to be smaller than 10 mm in this study. Therefore, vascular invasion in rectal NET with a small size can be concordantly assessed ([@B15], [@B16]). Pathological analyses used in treatment algorithms should be designed to ensure objectivity in the assessment of vascular invasion in NET. In addition to the utility of describing histological features of NET from different organs, NET classification can be a predictive or prognostic factor. Our result revealed that G2 classified tumors in the WHO 2010, although not an independent risk factor did show more frequent lymph node metastasis. However, this study did not investigate clinical outcomes and recurrence, and these associations with NET classification should be investigated in the future. Similarly, this study investigated only resectable tumors and distant metastasis was not investigated. Further clinicopathological analysis will be required to investigate risk factor of metachronal distant metastasis.

This multi-institutional study also provided extensive clinicopathological information about NET of the large intestine in Japan according to NET classifications. Rectal NET has been reported to occur with higher frequency among Asian/Pacific islanders ([@B16]). In this study, we also found a very high frequency of rectal NET in the Japanese population, and tumor distributions in the large intestine are thought to be much different from that seen in Western countries ([@B17]). Next, we also found site-dependent histological variation within the large intestine in the Japanese cohort ([@B18]). Over 90% of rectal carcinoids were NET G1, and the ratio was higher than that found in the colon or appendix. This predominant incidence of G1 in rectal NET is also higher than the 40--70% range of NET in other gastrointestinal organs reported previously ([@B19]--[@B23]). Therefore, this report revealed that in addition to the tumor size or invasion, the distribution of histological grade and type is also variable among rectal, colonic, and appendiceal NET in Asian populations. Furthermore, we first reported the incidence of MANEC in the colon and rectum; MANEC were found in 1.3% of total cases, and were more frequently seen in colonic NET. Further study will be required to establish a therapeutic strategy for MANEC. We succeeded to elucidate anatomical site-dependent histological variety of NET in large intestine using uniform classification. WHO 2010 criteria can be used to understand the histological and biological variety of NET within whole body.

In conclusion, the clinicopathological features of NET were variable among the rectum, colon, and appendix, and histological variability among them clearly emerged using the NET classification. In rectal NET, our study revealed lymph node metastases even in tumors smaller than 10 mm, demonstrating that indications for surgical resection should be re-examined, especially in small NET with vascular invasion.
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